Interim Clinical Commissioning Policy: Sarilumab for critically ill patients with COVID-19 pneumonia (adults)

Hospitalised pts are eligible for sarilumab if: COVID-19 is confirmed by testing or clinical and/or radiological features; and treated <24 hrs with respiratory support (high-flow nasal oxygen, CPAP or non-invasive or invasive mechanical ventilation).

Source:

Department of Health and Social Care